Literature DB >> 15371743

Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice.

Henriette Francès1, Bernard Le Foll, Jorge Diaz, Maria Smirnova, Pierre Sokoloff.   

Abstract

The dopamine D3 receptor (DRD3) mediates expression of conditioned effects of psychostimulants, but conflicting results have been obtained with opiates. In a conditioned place preference (CPP) procedure, morphine increased the time spent in a compartment previously paired with drug injection. CPP was obtained at morphine doses of 16 and 32 mg/kg in wild-type (drd3+/+) mice and 8, 16 and 32 mg/kg in DRD3-knockout (drd3-/-) mice. BP897, a DRD3-selective partial agonist, inhibited the expression of morphine-CPP in drd3+/+, but not drd3-/- mice. BP 897 reduced brain regional activation, measured by c-fos imaging after the CPP test session, in the somatosensory cortex of drd3+/+, but not drd3-/- mice. These results confirm the role of DRD3 in the expression of conditioned effects of morphine and the participation of the somatosensory cortex in these effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371743     DOI: 10.1097/00001756-200410050-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

Review 2.  An overview of the genetics of substance use disorders.

Authors:  H M Lachman
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

Review 3.  [Future medications for tobacco and cannabis dependence].

Authors:  Bernard Le Foll; Zuzana Justinova; Gianlugi Tanda; Steven R Goldberg
Journal:  Bull Acad Natl Med       Date:  2008-01       Impact factor: 0.144

Review 4.  Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor.

Authors:  R J Beninger; T J Banasikowski
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 5.  Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.

Authors:  Bernard Le Foll; Patricia Di Ciano
Journal:  Eur Neuropsychopharmacol       Date:  2014-09-16       Impact factor: 4.600

6.  Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice.

Authors:  Jia Zhan; Chloe J Jordan; Guo-Hua Bi; Xiang-Hu He; Eliot L Gardner; Yan-Lin Wang; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2018-08-20       Impact factor: 5.250

7.  The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.

Authors:  Ewa Galaj; Monica Manuszak; Sandra Babic; Subramaniam Ananthan; Robert Ranaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

8.  Neurochemical changes in brain induced by chronic morphine treatment: NMR studies in thalamus and somatosensory cortex of rats.

Authors:  Yun Xiang; Hongchang Gao; Hang Zhu; Ninglei Sun; Yuanye Ma; Hao Lei
Journal:  Neurochem Res       Date:  2006-10       Impact factor: 3.996

9.  Differential involvement of dopamine receptors in conditioned suppression induced by cocaine.

Authors:  Ivana Grakalic; Leigh V Panlilio; Eric B Thorndike; Charles W Schindler
Journal:  Eur J Pharmacol       Date:  2007-06-30       Impact factor: 4.432

10.  Somatosensory cortices are required for the acquisition of morphine-induced conditioned place preference.

Authors:  Zhiqiang Meng; Chang Liu; Xintian Hu; Yuanye Ma
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.